SoftBank-backed Neumora seeks $2.74 bln valuation in US IPO

Written by on September 11, 2023

Sept 11 (Reuters) - Neumora Therapeutics, backed by Amgen (AMGN.O) and Japan's SoftBank (9984.T), is seeking a valuation of up to $2.74 billion in its U.S . . .

Tagged as
Author

Black Hot Fire Network

Author's archive
You may also like
0

What’s keeping the U.S. from allowing sunscreens with better UV ray protection

May 4, 2024

0

How Does the World See the U.S. Campus Protests?

May 4, 2024

0

Narragansett named a best beach town in US by Thrillist. Here’s why.

May 4, 2024

Continue reading

Next post

Black holes may lie even closer to us than we thought, new study finds

Thumbnail
Previous post

How high school coaches are helping ensure 9/11 is never forgotten

Thumbnail
Current track

Title

Artist